Pattern of contraceptive use among women with sickle cell disease in Ibadan, South-west Nigeria

Journal of Obstetrics and Gynaecology

Volumn 30, Issue 2, 2010, Pages 171-174

  Okunlola, M A ^a   Olutayo, A A ^a   Okonkwo, N S ^a   Akingbola, T S ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Contraception; Ibadan; Nigeria; Sickle cell disease; Southwest; Women

Indexed keywords

INJECTABLE CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; AWARENESS; CONDOM; CONTRACEPTION; CROSS-SECTIONAL STUDY; DRUG INDUCED HEADACHE; EMERGENCY CONTRACEPTION; ENVIRONMENT; FEAR; FEMALE; HEADACHE; HEALTH CARE ACCESS; HEALTH EDUCATION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MENSTRUATION; NAUSEA; NIGERIA; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SIDE EFFECT; UNWANTED PREGNANCY; UTERINE TUBE LIGATION; VOMITING; WEIGHT GAIN;

ADULT; ANEMIA, SICKLE CELL; CONTRACEPTION BEHAVIOR; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NIGERIA; YOUNG ADULT;

EID: 76949099578     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443610903452799     Document Type: Article

References (23)

1. Akinyanju OO. 1989. A profile of sickle cell disease in Nigeria. Annals of the New York Academy of Sciences 565:126-136.
2. Asheley-Kopch A, Yang Q, Olney RS. 2000. Sickle hemoglobin (HbS) allele and sickle cell disease. A HUGE review. American Journal of Epidemiology 151:839-845.
3. Barbosa IC, Ladipo OA, Nascimento ML, Athayde C, Hirsch C, Lopes R et al. 2001. Carbohydrate metabolism in sickle cell patients using a subdermal implant containing nomegestrol acetate (Uniplant). Contraception 63:263-265.
4. Frederiksen MC. 1996. Depot medroxyprogesterone acetate contraception in women with medical problems. Journal of Reproductive Medicine 41:S414-S418.
5. Grimes DA. 1998. Oral contraceptive and sickle cell disease. The contraceptive report. CME Accreditation 8:9-11.
6. Harrison KA. 2003. Haemoglobinopathies in pregnancy. In: Lawson JB, Harrison KA, Bergstrom S, editors. Maternity care in developing countries. London: RCOG Press. pp 129-145.
7. Howard RJ, Lillis C, Tuck SM. 1993. Contraceptive counselling and pregnancy in women with sickle cell disease. British Medical Journal 306(6894):1735-1737.
8. Howard RJ, Tuck SM. 1994. Contraception and sickle cell disease. IPPF Medical Bulletin 28:3-4.
9. Koshy M. 1995. Sickle cell disease and pregnancy. Blood Review 9:157-164.
10. Kwawukume EY. 2002. Sickle cell disease in pregnancy. In: Kwawukume EY, Emuveyan EE, editors. Comprehensive obstetrics in the tropics. Dausoma: Ascites and Hittscher. pp 303-311.
11. Ladipo OA, Falusi AG, Feldblum PJ, Osotimehin BO, Otolorin EO, Ojengbede OA. 1993. Norplant use by women with sickle cell disease. International Journal of Gynaecology and Obstetrics 41:85-87.
12. Legardy JK, Curtis KM. 2006. Progestogen only contraceptive use among women with sickle cell anemia. A systematic review. Contraception 73:195-204.
13. Manchikanti A, Grimes DA, Lopez LM, Schulz KF. 2007. Steroid hormones for contraception in women with sickle cell disease. Cochrane Database of Systematic Reviews (2): CD006261.
14. Meremikwu MM. 2007. Sickle cell disease. BMJ Clinical Evidence 1752(8526): 2402.
15. Nascimento De L, Ladipo OA, Coutinho EM. 1998. Nomegestrol acetate contraceptive implant use by women with sickle cell disease. Clinical Pharmacology and Therapeutics 64:433-438.
16. Oteng-Ntim E, Chase AR, Howard J, Khazaezadeh N, Anionwu EN. 2008. Sickle cell disease in pregnancy. Obstetrics, Gynecology and Reproductive Medicine 18:272-278.
17. Oye-Adeniran BA, Adewole IF, Odeyemi KA, Ekanem EE, Umoh AV. 2005. Contraceptive prevalence among young women in Nigeria. Journal of Obstetrics and Gynaecology 25:182-185.
18. Population Reference Bureau. 2008. Enquiry Reference 1850: Sent Jan 2007: Faculty of Family Planning and Reproductive Health Care (FFPRHC) Clinical Effectiveness Unit. A Unit funded by the FFPRHC and supported by the University of Aberdeen to provide guidance on evidenced based practice. World Population Reference Bureau.
19. Sun PM, Wilburn W, Aynor BD, Jamieson D. 2001. Sickle cell disease in pregnancy-twenty years of experience at Grady Memorial Hospital, Atlanta Georgia. American Journal of Obstetrics and Gynecology 184:1127-1130.
20. Tamim H. 1997. Pregnancy. In: Eckman J, Platt A, editors. Sickle cell information centre guidelines. Atlanta: Sickle Cell Foundation of Georgia.
21. WHO. 2000. Medical eligibility criteria for contraceptive use, 3rd edn. Geneva: World Health Organization.
22. Yoong WC, Tuck SM, Yar Dumian A. 1999. Red cell, deformability in oral contraceptive pill users with sickle cell anaemia. British Journal of Haematology 104:868-870.
23. Yoong WC, Tuck SM, Pasi KJ, Owens D, Perry DJ. 2003. Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: Effect of differing forms of hormonal contraception. European Journal of Haematology 70:310-314.